| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Dexamethasone 100 microgram/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 100 microgram/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
2 |
| Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
2 |
| Product containing dexamethasone and tramazoline in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing dexamethasone and neomycin and polymyxin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing dexamethasone and neomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone- and tobramycin-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only ciprofloxacin and dexamethasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dexamethasone and neomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone and neomycin and polymyxin B only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone and tobramycin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dexamethasone and tramazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone and tramazoline only product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone and tobramycin only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dexamethasone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone only product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dexamethasone in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dexamethasone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 1 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 1 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 700 microgram prolonged-release ocular implant |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 700 microgram prolonged-release ocular implant |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dexamethasone and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone and hypromellose only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL and dexamethasone 1 mg/mL ear suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL and dexamethasone 1 mg/mL ear suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin and dexamethasone only product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin- and dexamethasone-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing dexamethasone and hypromellose in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing dexamethasone and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dexamethasone and ofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dexamethasone and ofloxacin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing dexamethasone and ofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing dexamethasone and ofloxacin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dexamethasone and neomycin and polymyxin B in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone- and levofloxacin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dexamethasone and levofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone- and levofloxacin-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dexamethasone and levofloxacin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and levofloxacin 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
2 |
| Injection of dexamethasone during maternal intrapartum period (procedure) |
Direct substance |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Injection of dexamethasone during maternal pregnancy period |
Direct substance |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only chloramphenicol and dexamethasone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only chloramphenicol and dexamethasone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing chloramphenicol and dexamethasone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing chloramphenicol and dexamethasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only chloramphenicol and dexamethasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing dexamethasone and neomycin and polymyxin B in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]